Pharmacotherapeutics for Nurse Practitioners Quotes
Pharmacotherapeutics for Nurse Practitioners
by
Teri Moser Woo2 ratings, 4.00 average rating, 0 reviews
Pharmacotherapeutics for Nurse Practitioners Quotes
Showing 1-3 of 3
“Type A reactions are dose dependent, common, and
related to the pharmacological effects of the drug.
Type B reactions are allergic or idiosyncratic reactions; they are not dose dependent and are usually
not predictable or preventable.
Type C reactions are related to the cumulative dose
of the medication; they are dose and time related,
and they are relatively uncommon.”
― Pharmacotherapeutics for Nurse Practitioners
related to the pharmacological effects of the drug.
Type B reactions are allergic or idiosyncratic reactions; they are not dose dependent and are usually
not predictable or preventable.
Type C reactions are related to the cumulative dose
of the medication; they are dose and time related,
and they are relatively uncommon.”
― Pharmacotherapeutics for Nurse Practitioners
“Prescribing a drug results from clinical judgment based
on a thorough assessment of the patient and the patient’s
environment, the determination of medical and nursing
diagnoses, a review of potential alternative therapies, and
specific knowledge about the drug chosen and the disease process it is designed to treat. In general, the best therapy is the least invasive, least expensive, and least likely to
cause adverse reactions. Frequently, the choice is to have
nonpharmacological and pharmacological therapies
working together.”
― Pharmacotherapeutics for Nurse Practitioners
on a thorough assessment of the patient and the patient’s
environment, the determination of medical and nursing
diagnoses, a review of potential alternative therapies, and
specific knowledge about the drug chosen and the disease process it is designed to treat. In general, the best therapy is the least invasive, least expensive, and least likely to
cause adverse reactions. Frequently, the choice is to have
nonpharmacological and pharmacological therapies
working together.”
― Pharmacotherapeutics for Nurse Practitioners
“The Nurse
Practitioner and an issue of The American Journal for Nurse
Practitioners present a summary of each state’s practice
acts as they relate to titling, roles, and prescriptive authority. As of January 2009 (Pearson, 2009; Phillips, 2009),”
― Pharmacotherapeutics for Nurse Practitioners
Practitioner and an issue of The American Journal for Nurse
Practitioners present a summary of each state’s practice
acts as they relate to titling, roles, and prescriptive authority. As of January 2009 (Pearson, 2009; Phillips, 2009),”
― Pharmacotherapeutics for Nurse Practitioners